Get startedLog in
    Picture of Johnson & Johnson logo

    JNJ — Johnson & Johnson News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    All News

    Contineum, J&J's depression drug fails to meet mid-stage trial goal

    Picture of Johnson & Johnson logoJohnson & Johnson
    14/09/2026 21:11
    Contineum, J&J's depression drug fails to meet mid-stage trial goal
    Sept 15 (Reuters) - Contineum Therapeutics CTNM.O said on Monday an experimental depression drug it developed with Johnson & Johnson JNJ.N failed to meet the main goal of a mid-stage study.









     (Reporting by Kamal Choudhury in Bengaluru; Editing by Arun Koyyur)
     ((Kamal.Choudhury@thomsonreuters.com;))

    Recent news on Johnson & Johnson

    See all news